IGF2BP1 and neuroblastoma: Furthermore, we demonstrate that the combination of IGF2BP1 inhibition along with commonly used chemotherapeutics that broadly effect DNA synthesis, or cyclin dependent kinase (CDK) inhibitors that disrupt signal transduction, have a synergistic effect on suppressing neuroblastoma cell proliferation.